{
    "id": 16855,
    "fullName": "FGFR1 V561M",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "FGFR1 V561M lies within the protein kinase domain of the Fgfr1 protein (UniProt.org), V561M is predicted to confer a gain of function to the Fgfr1 protein, as demonstrated by increased Fgfr1 autophosphorylation in cell culture, and has also been demonstrated to confer resistance to tyrosine kinase inhibitors (PMID: 25686244, PMID: 15157880, PMID: 28646488).",
            "references": [
                {
                    "id": 4375,
                    "pubMedId": 15157880,
                    "title": "Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15157880"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 15341,
                    "pubMedId": 28646488,
                    "title": "Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28646488"
                },
                {
                    "id": 4376,
                    "pubMedId": 25686244,
                    "title": "Illuminating the molecular mechanisms of tyrosine kinase inhibitor resistance for the FGFR1 gatekeeper mutation: the Achilles' heel of targeted therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25686244"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2260,
        "geneSymbol": "FGFR1",
        "terms": [
            "FGFR1",
            "bFGF-R-1",
            "BFGFR",
            "CD331",
            "CEK",
            "ECCL",
            "FGFBR",
            "FGFR-1",
            "FLG",
            "FLT-2",
            "FLT2",
            "HBGFR",
            "HH2",
            "HRTFDS",
            "KAL2",
            "N-SAM",
            "OGD"
        ]
    },
    "variant": "V561M",
    "createDate": "01/19/2016",
    "updateDate": "06/13/2019",
    "referenceTranscriptCoordinates": {
        "id": 155135,
        "transcript": "NM_023110",
        "gDna": "chr8:g.38416043C>T",
        "cDna": "c.1681G>A",
        "protein": "p.V561M",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16205,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, non-small cell lung cancer cells expressing FGFR1 V561M demonstrated resistance to AZD4547 in culture (PMID: 30257990).",
            "molecularProfile": {
                "id": 17133,
                "profileName": "FGFR1 V561M"
            },
            "therapy": {
                "id": 654,
                "therapyName": "AZD4547",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 14329,
                    "pubMedId": 30257990,
                    "title": "The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30257990"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12820,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PRN1371 inhibited proliferation of transformed cells over expressing FGFR1 V561M in culture (PMID: 28978721).",
            "molecularProfile": {
                "id": 17133,
                "profileName": "FGFR1 V561M"
            },
            "therapy": {
                "id": 3583,
                "therapyName": "PRN1371",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 10753,
                    "pubMedId": 28978721,
                    "title": "The Irreversible Covalent Fibroblast Growth Factor Receptor Inhibitor PRN1371 Exhibits Sustained Inhibition of FGFR after Drug Clearance.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28978721"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4026,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, FIIN-01 inhibited Fgfr1 autophosphorylation in a human transformed embryonic kidney cell line harboring FGFR1 V561M mutation in culture (PMID: 20338520).",
            "molecularProfile": {
                "id": 17133,
                "profileName": "FGFR1 V561M"
            },
            "therapy": {
                "id": 2507,
                "therapyName": "FIIN-1",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2410,
                    "pubMedId": 20338520,
                    "title": "A structure-guided approach to creating covalent FGFR inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20338520"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16206,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, knockdown of STAT3 using shRNA sensitized non-small cell lung cancer cells expressing FGFR1 V561M to AZD4547 in culture, resulting in decreased cell viability (PMID: 30257990).",
            "molecularProfile": {
                "id": 31532,
                "profileName": "FGFR1 V561M STAT3 dec exp"
            },
            "therapy": {
                "id": 654,
                "therapyName": "AZD4547",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 14329,
                    "pubMedId": 30257990,
                    "title": "The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30257990"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 17133,
            "profileName": "FGFR1 V561M",
            "profileTreatmentApproaches": [
                {
                    "id": 7455,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR1 V561M"
                },
                {
                    "id": 7454,
                    "name": "FGFR1 Inhibitor",
                    "profileName": "FGFR1 V561M"
                }
            ]
        },
        {
            "id": 31532,
            "profileName": "FGFR1 V561M STAT3 dec exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 155137,
            "transcript": "XM_017013221",
            "gDna": "chr8:g.38416043C>T",
            "cDna": "c.1681G>A",
            "protein": "p.V561M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155138,
            "transcript": "XM_006716304",
            "gDna": "chr8:g.38416043C>T",
            "cDna": "c.1681G>A",
            "protein": "p.V561M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155136,
            "transcript": "XM_006716303",
            "gDna": "chr8:g.38416043C>T",
            "cDna": "c.1681G>A",
            "protein": "p.V561M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 155135,
            "transcript": "NM_023110",
            "gDna": "chr8:g.38416043C>T",
            "cDna": "c.1681G>A",
            "protein": "p.V561M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}